Results 191 to 200 of about 4,031,675 (267)

Correlative Ultrafast Imaging of a Photodriven Phase Transition Using 4D Scanning Transmission Electron Microscopy. [PDF]

ACS Nano
Niedermayr A, Wu J, Fisher B, Kaminer I, Weissenrieder J.   +4 more
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

Mesenchymal hamartoma of the liver in a young adult female: a diagnostic challenge mimicking hepatic adenoma. [PDF]

J Surg Case Rep
Saruta Y, Kawaguchi Y, Nishioka Y, Ichida A, Takamoto T, Akamatsu N, Hasegawa K.   +6 more
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Automatic identification of compounds in molecular mixtures from liquid-phase infrared spectra. [PDF]

Chem Sci
Melle YJU, Nguyen T, Lopez J, Schwalbe-Koda D.   +3 more
europepmc   +1 more source

Dissecting the propensity of RIM1 subdomains to form phase condensates. [PDF]

Sci Rep
Kersten L, Galkov M, Nemcova P, Mostafa AHD, Quatraccioni A, Dietrich D, Schoch S.   +6 more
europepmc   +1 more source

Energy Expenditure Optimization in the Echolocation of <i>Rhinolophus nippon</i>: Evidence from Heart Rate Stability. [PDF]

Biology (Basel)
Zhang M, Qi W, Han B, Han F, Gu H, Zhang K, Liu Y.   +6 more
europepmc   +1 more source

Sleep Characteristics and Menstrual Cycle Phase-Based Differences in Sleep in Naturally Menstruating Elite Female Team Sport Athletes. [PDF]

Eur J Sport Sci
McGeever A, Mallon N, Bruinvels G, Pedlar CR, Doherty R, van Someren KA.   +5 more
europepmc   +1 more source